A141080 Stock Overview
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
LigaChem Biosciences Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩102,700.00 |
52 Week High | ₩106,900.00 |
52 Week Low | ₩32,400.00 |
Beta | 1.07 |
11 Month Change | 4.80% |
3 Month Change | 43.04% |
1 Year Change | 176.82% |
33 Year Change | 124.48% |
5 Year Change | 324.82% |
Change since IPO | 1,073.71% |
Recent News & Updates
LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Sep 09Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money
May 23Recent updates
LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Sep 09Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money
May 23A Look At The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)
Mar 29What Kind Of Shareholders Hold The Majority In LegoChem Biosciences, Inc.'s (KOSDAQ:141080) Shares?
Jan 28Estimating The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)
Dec 07Shareholder Returns
A141080 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | 15.1% | 9.1% | 2.5% |
1Y | 176.8% | 60.0% | 4.6% |
Return vs Industry: A141080 exceeded the KR Life Sciences industry which returned 60% over the past year.
Return vs Market: A141080 exceeded the KR Market which returned 4.6% over the past year.
Price Volatility
A141080 volatility | |
---|---|
A141080 Average Weekly Movement | 9.7% |
Life Sciences Industry Average Movement | 10.1% |
Market Average Movement | 6.7% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A141080's share price has been volatile over the past 3 months.
Volatility Over Time: A141080's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 157 | Yong Kim | www.legochembio.com |
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies.
LigaChem Biosciences Inc. Fundamentals Summary
A141080 fundamental statistics | |
---|---|
Market cap | ₩3.74t |
Earnings (TTM) | -₩33.95b |
Revenue (TTM) | ₩76.22b |
49.1x
P/S Ratio-110.2x
P/E RatioIs A141080 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A141080 income statement (TTM) | |
---|---|
Revenue | ₩76.22b |
Cost of Revenue | ₩16.02b |
Gross Profit | ₩60.20b |
Other Expenses | ₩94.14b |
Earnings | -₩33.95b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -931.92 |
Gross Margin | 78.98% |
Net Profit Margin | -44.54% |
Debt/Equity Ratio | 1.9% |
How did A141080 perform over the long term?
See historical performance and comparison